相关实验视频
Updated: Jul 27, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
在没有获得胰岛素的囚犯中糖尿病酸症
A S Keller1, R N Link, N A Bickell
1Department of Medicine, University School of Medicine, New York, NY.
JAMA
|February 3, 1993
概括
男性囚犯的糖尿病酸性脂肪酸症通常是由逮捕后缺乏胰岛素引起的. 改善监禁糖尿病患者获得医疗保健的机会至关重要.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病酸症 (DKA) 是糖尿病的一种严重并发症.
- 监禁人口在管理糖尿病等慢性疾病时可能面临独特的挑战.
研究的目的:
- 在纽约市的男性囚犯中调查DKA的原因和临床严重程度.
- 在这个人口群体中确定导致DKA入学的因素.
主要方法:
- 进行了回顾性图表审查.
- 分析了1989年至1991年间在成年男性囚犯中因DKA入院54次的数据.
主要成果:
- 70%的DKA入院是由于停药后缺乏胰岛素,入院平均延迟2.5天.
- 患者有胰岛素依赖性糖尿病病史,并且在停药前符合规定.
- 平均血清葡萄糖为27.4 mmol/L,平均血清碳酸盐为14.4 mmol/L,平均住院时间为3.4天.
结论:
- 无法获得必需药物,特别是胰岛素,导致最近被捕的胰岛素依赖糖尿病囚犯的严重健康后果.
- 对于新入狱的糖尿病患者来说,有必要加强医疗保健的准入,以预防DKA并改善结果.
相关概念视频
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

